| (210) | Number of the EPO application | 16733268 |
| (220) | Filing date of the EPO application | 2016.06.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 40/2020, 2020.09.30 |
| (110) | EPO patent number | 3310371 |
| (11) | Number of the document | MD 3310371 T2 |
| (21) | Number of the application | e 2018 0406 |
| (71) | Name(s) of applicant(s), code of the country | ELI LILLY AND COMPANY, US; |
| (72) | Name(s) of inventor(s), code of the country | CHEN Yanyun, US;
MEZO Adam Robert, US;
QU Hongchang, US;
VALENZUELA Francisco Alcides, US; |
| (73) | Name(s) of owner(s), code of the country | ELI LILLY AND COMPANY, US; |
| (54) | Title of the invention | Glucagon and GLPl-1 co-agonist compounds |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 38/00 (2006.01.01); A61K 38/26 (2006.01.01); C07K 14/605 (2006.01.01); C07K 14/00 (2006.01.01); A61P 3/00 (2006.01.01); A61P 1/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.06.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2020.12.31 |
| (30) | Priority | 201562182847 P, 2015.06.22, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2016/037818, 2016.06.16 |
| (87) | International publication | WO 2016/209707, 2016.12.29 |